£495.00

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

2023-2028 Anaplastic Thyroid Cancer Drugs Outlook - Japan

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 38 days · 38 data points (no recent data)

Historical
Generating forecast…
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 22 August 2026 31 August 2026 09 September 2026 18 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 53 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 38 days • 1 price levels

Days at Price
38 days 0 10 19 29 38 £495 Days at Price

Price Analysis

Most common price: £495 (38 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 38 days

Description

This comprehensive market research study analyses the latent demand outlook for anaplastic thyroid cancer drugs across Japan's prefectures and cities. The report provides potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for over 1,000 Japanese cities, enabling precise market assessment at regional and national levels. Each city analysis includes percentage share data relative to its prefecture and Japan as a whole, offering comparative benchmarks for rapid market evaluation. The study employs econometric models to project future demand trends, making it an essential resource for pharmaceutical distribution strategies, sales force planning, and market penetration analysis across Japan's healthcare landscape.

Key Features

Covers latent demand outlook for anaplastic thyroid cancer drugs across all Japanese prefectures and major cities.

Provides potential industry earnings estimates in millions of U.S. dollars for over 1,000 cities in Japan.

Includes percentage share calculations for each city relative to its prefecture and national market position.

Uses econometric models to project future market trends and demand patterns through 2028.

Offers comparative benchmarks and data analysis tools for evaluating city-level market opportunities.

Designed specifically for pharmaceutical distribution and sales force strategy development in Japan.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Thyroid Gland Disorders in India
92% match

The 2023-2028 Outlook for Thyroid Gland Disorders in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in the United States
91% match

The 2023-2028 Outlook for Thyroid Gland Disorders Treatments in the United States

£520.00 27 Sep 2026
2023-2028 Monoclonal Antibodies Outlook for Japan - mAbs Market
91% match

2023-2028 Monoclonal Antibodies Outlook for Japan - mAbs Market

£495.00 28 Sep 2026
The 2023-2028 Outlook for Thyroid Gland Disorders Treatments for US Zip Codes
91% match

The 2023-2028 Outlook for Thyroid Gland Disorders Treatments for US Zip Codes

£490.00 27 Sep 2026
2023-2028 Traveler's Diarrhea Treatments Japan Market Outlook
91% match

2023-2028 Traveler's Diarrhea Treatments Japan Market Outlook

£495.00 28 Sep 2026
2023-2028 Bronchitis Treatment Outlook for Japan
90% match

2023-2028 Bronchitis Treatment Outlook for Japan

£495.00 28 Sep 2026
2023-2028 Liver Cirrhosis Drugs Outlook Japan - Market Analysis
90% match

2023-2028 Liver Cirrhosis Drugs Outlook Japan - Market Analysis

£495.00 28 Sep 2026
2023-2028 Cognitive Memory Enhancer Drugs Outlook Japan
89% match

2023-2028 Cognitive Memory Enhancer Drugs Outlook Japan

£495.00 28 Sep 2026
The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States
89% match

The 2023-2028 Outlook for Triple-Negative Breast Cancer Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Immune-Oncology Treatments in India
89% match

The 2023-2028 Outlook for Immune-Oncology Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in the United States
89% match

The 2023-2028 Outlook for GLP-1 Agonists for Type 2 Diabetes in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
89% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Allergic Rhinitis in Japan
89% match

The 2023-2028 Outlook for Allergic Rhinitis in Japan

£495.00 15 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States
89% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Genital Herpes Treatments in Japan
88% match

The 2023-2028 Outlook for Genital Herpes Treatments in Japan

£495.00 24 Oct 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
88% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
2023-2028 Actinic Keratosis Treatment Outlook Japan
88% match

2023-2028 Actinic Keratosis Treatment Outlook Japan

£495.00 28 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India
88% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India
88% match

The 2023-2028 Outlook for Cutaneous Melanoma Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
88% match

The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States

£520.00 27 Sep 2026
2023-2028 Artificial Tears Market Outlook Japan - Cities & Prefectures
88% match

2023-2028 Artificial Tears Market Outlook Japan - Cities & Prefectures

£495.00 28 Sep 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States
88% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Malignant Melanoma Treatments in India
88% match

The 2023-2028 Outlook for Malignant Melanoma Treatments in India

£515.00 27 Sep 2026
2023-2028 Oral Iron Therapy Outlook - Japan Market Analysis
88% match

2023-2028 Oral Iron Therapy Outlook - Japan Market Analysis

£495.00 28 Sep 2026